Novavax Inc. Stock Falls Thursday, Underperforms Market
This article was automatically generated by MarketWatch using technology from Automated Insights.
Shares of Novavax Inc. (NVAX) slid 6.89% to $11.62 Thursday, on what proved to be an all-around grim trading session for the stock market, with the NASDAQ Composite Index falling 0.96% to 10,852.27 and Dow Jones Industrial Average falling 0.76% to 33,044.56. The stock's fall snapped a three-day winning streak. Novavax Inc. closed $89.77 short of its 52-week high ($101.39), which the company reached on February 7th.
The stock underperformed when compared to some of its competitors Thursday, as Johnson & Johnson (JNJ) fell 0.14% to $169.53, Pfizer Inc. (PFE) fell 0.09% to $44.96, and Merck & Co. Inc. (MRK) rose 1.02% to $109.90. Trading volume (6.1 M) remained 886,799 below its 50-day average volume of 7.0 M.
Data source: Dow Jones Market Data, FactSet. Data compiled Janurary 19, 2023.
(END) Dow Jones Newswires
January 19, 2023 17:14 ET (22:14 GMT)
Copyright (c) 2023 Dow Jones & Company, Inc.